Approximately one in 1,000 patients with diabetes have a major amputation each year, corresponding to 5-6 times higher risk ...

The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...

Zepbound® (tirzepatide) provided a 47% greater relative weight loss compared to Wegovy® (semaglutide ... Higher than Industry Standards SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE ...

The popular Conophytum, Lithops and Tylecodon are part of the group of rare and aesthetically unique succulents which are now ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

In 2030, Morocco will co-host the FIFA World Cup alongside Spain and Portugal, making it the second nation on the continent (after South Africa) to hold the football tournament. Plans are already ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

South Africa seal 10-wicket win in the second Test to win the series 2-0 despite Pakistan’s late fightback in Cape Town. Nigeria’s military launch offensive on new rebel group Nigeria’s ...

Many viewers of the 2025 Golden Globes quickly noticed stars who seemed to have embraced GLP-1 medications that help people ...

Bangladesh has cancelled the participation of its judicial officials in training sessions in India, following directives from its Supreme Court. The training, a bilateral agreement from Prime ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Jan 3 | The developer is seeking over eight figures in damages over two delayed projects amid a dispute between partners. Jan 3 | The loan was set to mature later this year, and the lawsuit ...